This was Buch's life for four years until professor of neurosurgery Dr. Sean Lew recommended the responsive neurostimulation procedure, or RNS. "For epilepsy surgery, traditionally, the treatment ...

UBS analysts highlight NeuroPace's RNS technology as a unique and clinically validated solution for the significantly underserved and underpenetrated drug-resistant epilepsy (DRE) market.

When medications are insufficient, other treatments such as vagus nerve stimulation (VNS), responsive neurostimulation (RNS), deep brain stimulation (DBS), and even epilepsy surgery may be ...

NeuroPace is known for its innovative RNS System, the first brain-responsive platform that provides personalized treatment to manage seizures in patients with drug-resistant epilepsy, potentially ...

After experiencing seizures every other week, Christine Kauzen has been seizure-free for months since receiving a rare ...

using real-world data from children treated with RNS therapy across 27 pediatric epilepsy centers to support an expansion in indication for use; FDA submission anticipated in second half of 2025 ...

This article is authored by Dr Amit Kumar Agarwal, senior consultant, neurosciences, neurology and stroke medicine, Amrita Hospital, Faridabad.

Based in Mountain View, Calif., NeuroPace is a medical device company focused on transforming the lives of people living with epilepsy by reducing or eliminating the occurrence of debilitating ...

RN reviews safety, expectations ... Buchhalter, PhD MD, is the former director of the pediatric epilepsy program in the Mayo Clinic Department of Neurology, Rochester, MN.

“We have several ongoing clinical programs examining the RNS System in expanded patient populations and new indications in epilepsy that are expected to announce data or have regulatory events ...